Coffee consumption habits impact the risk of mild cognitive impairment

July 28, 2015, IOS Press
Credit: George Hodan/public domain

A new study by researchers at the University of Bari Aldo Moro, Bari, Italy, Geriatric Unit & Laboratory of Gerontology and Geriatrics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy, and Istituto Superiore di Sanità (ISS), Roma, Italy, estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment (MCI), evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging (ILSA), a population-based sample from eight Italian municipalities with a 3.5-year median follow-up. These findings are published in the Journal of Alzheimer's Disease.

Mild (MCI) is considered a prodromal stage of Alzheimer's disease (AD) and dementia. As no effective treatment exists to modify the natural history of this neurodegenerative disorder, the identification and subsequent management of risk/protective factors may be crucial for prevention of MCI and its progression to AD and dementia. Among diet-associated factors, coffee is regularly consumed by millions of people around the world and owing to its caffeine content, it is the best known psychoactive stimulant resulting in heightened alertness and arousal and improvement of cognitive performance.

Besides short-term effects of caffeine-containing beverages, some case-control and cross-sectional and longitudinal population-based studies evaluated the long-term effects on brain function and provided evidence that coffee, tea, or caffeine consumption or higher plasma caffeine levels may be protective against cognitive impairment and dementia, with some notable exceptions.

An interesting finding in this study was that cognitively normal older individuals who modified their habits by increasing with time their amount of coffee consumption (> 1 cup of coffee/day) had about two times higher rate of MCI compared to those with reduced habits (< 1 cup of coffee/day) and about one and half time higher rate of MCI in comparison with those with constant habits (neither more nor less 1 coffee/day). Moreover, those who habitually consumed moderate amount of coffee (1 or 2 cups of coffee/day) had a reduced rate of the incidence of MCI than those who habitually never or rarely consumed coffee. No significant association was verified between who habitually consumed higher levels of coffee consumption (> 2 cups of coffee/day) and the incidence of MCI in comparison with those who never or rarely consumed coffee.

"These findings from the Italian Longitudinal Study on Aging suggested that cognitively normal older individuals who never or rarely consumed coffee and those who increased their coffee consumption habits had a higher risk of developing MCI. Therefore, moderate and regular coffee consumption may have neuroprotective effects also against MCI confirming previous studies on the long-term protective effects of coffee, tea, or caffeine consumption and plasma levels of caffeine against cognitive decline and dementia," said investigators Vincenzo Solfrizzi, MD, PhD, and Francesco Panza, MD, PhD, University of Bari Aldo Moro, Bari, Italy.

The authors hypothesized different potential mechanisms in explaining the neuroprotective effects of observed in this study. The long-term neuroprotective effect of caffeine may involve competitive antagonism of excessive activation of adenosine A2A receptors (A2ARs), which may attenuate damage caused by beta-amyloid (A-beta), the toxic peptide accumulating in AD brains. Indeed, both acute or long-term caffeine administration were shown to reduce brain A-beta levels in AD transgenic mice and memory restoration and reversal of AD pathology in mice with pre-existing A-beta burden. Adenosine is a neuromodulator that operates via the most abundant inhibitory adenosine A1 receptors (A1Rs) and the less abundant, but widespread, facilitatory A2ARs. A1Rs play a key role in neuroprotection, decreasing glutamate release and hyperpolarizing neurons, and their activation attenuates brain damage, whereas their blockade exacerbates damage in adult animals.

In contrast, A2ARs blockade confers robust brain neuroprotection in adult animals. Moreover, while central A1Rs are down-regulated by chronic noxious situations, the brain neuroprotective effect of A2AR antagonists is maintained in chronic noxious brain conditions without observable peripheral effects, thus justifying the interest of A2AR antagonists as novel protective agents in neurodegenerative diseases such as AD. Therefore, the ability of caffeine to prevent memory deterioration in animal models of aging or AD may be related to the action of A2ARs rather than A1Rs, suggesting that an adequate adenosinergic tonus is required for normal memory performance and that over- or down-activation of the adenosine system may result in impaired memory functioning.

This hypothesis could in part explain why, as shown in this study, both no or rare and higher consumption of coffee (> 2 cups/day) were associated with higher risk of the incidence of MCI. Accordingly, moderate doses of caffeine improve memory performance in rodents, whereas higher doses of caffeine may impair memory acquisition. Biological effects of caffeine on brain function also included modulation of white matter lesions and/or microvascular ischemic lesions, and improved insulin sensitivity, so reducing the risk of type 2 diabetes, which is a strong risk factor for cognitive decline. Moreover, could in part compensate the cognitive decline in older individuals because its effects on vigilance and attention, mainly in situations of reduced alertness. Finally, habitual and moderate consumption of coffee may prevent MCI through attenuation of subclinical neuroinflammation, and reduction in oxidative stress.

The authors concluded: "More sensitive outcomes such as findings from neuroimaging studies should become available from experimental data, so further explaining the mechanisms underlying the neuroprotective effects of coffee, tea, and . Larger studies with longer follow-up periods should be encouraged, addressing other potential bias and confounding sources, so hopefully opening new ways for diet-related prevention of dementia and AD."

Explore further: Caffeine's effect on the brain's adenosine receptors visualized for the first time

More information: "Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging," by Vincenzo Solfrizzi, Francesco Panza, Bruno P. Imbimbo, Alessia D'Introno, Lucia Galluzzo, Claudia Gandin, Giovanni Misciagna, Vito Guerra, Alberto Osella, Marzia Baldereschi, Antonio Di Carlo, Domenico Inzitari, Davide Seripa, Alberto Pilotto, Carlo Sabbá, Giancarlo Logroscino, Emanuele Scafato, DOI: 10.3233/JAD-150333, published online in advance of the Journal of Alzheimer's Disease, Volume 47, Issue 4 (September 2015).

Related Stories

Caffeine's effect on the brain's adenosine receptors visualized for the first time

November 1, 2012
Molecular imaging with positron emission tomography (PET) has enabled scientists for the first time to visualize binding sites of caffeine in the living human brain to explore possible positive and negative effects of caffeine ...

Moderate coffee consumption may lower the risk of Alzheimer's disease by up to 20 percent, study suggests

November 27, 2014
Drinking 3-5 cups of coffee per day may help to protect against Alzheimer's Disease, according to research highlighted in an Alzheimer Europe session report published by the Institute for Scientific Information on Coffee ...

Is there a link between coffee drinking and mortality?

February 19, 2013
(Medical Xpress)—A large study of nearly half a million older adults followed for about 12 years revealed a clear trend: as coffee drinking increased, the risk of death decreased. Study author Neal Freedman, PhD, MPH, National ...

High blood caffeine levels in older adults linked to avoidance of Alzheimer's disease

June 4, 2012
Tampa, FL (June 4, 2012) Those cups of coffee that you drink every day to keep alert appear to have an extra perk – especially if you're an older adult. A recent study monitoring the memory and thinking processes of ...

Researchers find possible molecular explanation for caffeine reducing mood disorders

June 9, 2015
(Medical Xpress)—An international team of researchers has found a possible molecular explanation for the stress reducing capabilities of caffeine. In their paper published in Proceedings of the National Academy of Sciences, ...

Recommended for you

Scientists reveal ground-breaking plan to target cause of Alzheimer's disease

September 24, 2018
A breakthrough has been made in the fight against Alzheimer's disease—researchers have found a new way to target the toxic particles that destroy healthy brain cells.

In landmark study, doctors say test identifies people most likely to get Alzheimer's

September 24, 2018
The beginning was the worst. It frustrated Janet Parkerson when her father started to forget what he had done that day or the day before.

Study clarifies ApoE4's role in dementia

September 20, 2018
ApoE4, a protein linked to both Alzheimer's disease and a form of dementia caused by damage of blood vessels in the brain, increases the risk of cognitive impairment by reducing the number and responsiveness of blood vessels ...

Machine learning IDs markers to help predict Alzheimer's

September 19, 2018
Nearly 50 million people worldwide have Alzheimer's disease or another form of dementia. These irreversible brain disorders slowly cause memory loss and destroy thinking skills, eventually to such an extent that self-care ...

Discovery could explain failed clinical trials for Alzheimer's, and provide a solution

September 19, 2018
Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trials have failed. The study also identifies a clinically ...

Air pollution may be linked to heightened dementia risk

September 18, 2018
Air pollution may be linked to a heightened risk of developing dementia, finds a London-based observational study, published in the online journal BMJ Open. The associations found couldn't be explained by factors known to ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jul 28, 2015
Doesn't everything?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.